Thymodepressin inhibits migration of CD34+ cells from bone marrow in normal and granulocyte CSF-stimulated hemopoiesis.
Animal research · 2007
- What was studied
- The available record identifies the subject in the title but gives no verified sample details.
- Main finding
- Mouse CD34-positive cell distribution and adhesion-marker changes suggest altered trafficking. They do not identify a direct molecular receptor or demonstrate human stem-cell expansion.
Study data at a glance
- Participants or experimental model
- See original report; human, animal and laboratory components must be distinguished.
- Reported results
- Mouse CD34-positive cell distribution and adhesion-marker changes suggest altered trafficking. They do not identify a direct molecular receptor or demonstrate human stem-cell expansion.
Study limitations and source details
Study limitations
- The abstract leaves the preparation and study methods unclear.
- Related publications may share experiments; source count is not independent-study count.
Source details
Indexed metadata and abstract checked via Europe PMC. Original full methods not reviewed.
Sources checked
Citation
Semina OV, Semenets TN, Zamulaeva IA, Selivanova EI, Il'ina TP, Malyutina YV, Semin DY, Deigin VI, Saenko AS.. Thymodepressin inhibits migration of CD34+ cells from bone marrow in normal and granulocyte CSF-stimulated hemopoiesis. Bulletin of experimental biology and medicine
Study source ↗ · DOI 10.1007/s10517-007-0442-y · Bibliography entry · Link to this summary